VIDEO: Quarterly intervals an option for individualized dosing of anti-angiogenics

VANCOUVER, British Columbia ― David Eichenbaum, MD, discusses quarterly dosing of anti-angiogenics for neovascular macular degeneration, data he presented at the American Society of Retina Specialists meeting. 

Full Story →